Ready to ship!

Ertugliflozin for Horses with Hyperinsulinemia-Associated Laminitis

Ready to ship!

Ertugliflozin for Horses with Hyperinsulinemia-Associated Laminitis

Ready to Ship!

Ertugliflozin for Horses with Hyperinsulinemia-Associated Laminitis

Insulin Not Coming Down?

Improve recovery from hyperinsulinemia-associated laminitis with Ertugliflozin

Using SGLT2 inhibitors for laminitis.

Hear directly from Dr. Tania Sundra, BSc.(Hons) BVMS MANZCVS (Equine Medicine) about when to use SGLT2 inhibitors, including for short-term use, emergency use, preventative use, and for chronic management of hyperinsulinemia.

Join Us for Upcoming Equine Webinars!

PPID Part 1: Diagnosis of PPID, Value of The TRH Stimulation Test

PPID webinar series part 1 will review the available diagnostic tests available to practitioners to diagnose pituitary pars inter media dysfunction (PPID). The session will focus on the use of the thyrotropin-releasing hormone (TRH) stimulation test in the diagnosis and the follow-up of clinical cases.

March 25 | 7 p.m. ET

A Novel Pharmacological Tool: Clinical Use of Ertugliflozin in Horses with Hyperinsulinemia and Laminitis

This webinar explores ertugliflozin as a treatment for equine hyperinsulinemia, using real-world case examples and emerging evidence. It will address patient selection, treatment and monitoring strategies, and practical considerations for applying research to everyday clinical care in horses at risk of metabolic disease and laminitis.

April 1 | 8 p.m. ET

PPID Part 2: Management of PPID, Pergolide and Beyond!

PPID webinar series part 2 will consider the pharmaceutical and non-pharmaceutical options for the management of pituitary pars intermedia dysfunction, including nutrition of the geriatric horse and new compounds available. April 8 | 7 p.m. ET

Start an Order for Your Practice

View all products, bulk pricing, expiration dates, and order online at iFill.com. New to iFill? Register for an account!